lorazepam has been researched along with ucb 34714 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gevins, A; Leese, PT; Loring, DW; Meador, KJ; Otoul, C | 1 |
| Greve, B; Moseley, BD; Sadek, A; Szaflarski, JP; Varner, JA; Williams, P | 2 |
| Panda, PK; Saini, K; Sharawat, IK | 1 |
2 trial(s) available for lorazepam and ucb 34714
| Article | Year |
|---|---|
Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam.
Topics: Adolescent; Adult; Anticonvulsants; Blood Cell Count; Cognition; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Humans; Levetiracetam; Lorazepam; Male; Memory, Short-Term; Mental Recall; Middle Aged; Neuropsychological Tests; Piracetam; Pyrrolidinones; Sample Size; Treatment Outcome; Young Adult | 2011 |
Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Anticonvulsants; Dizziness; Double-Blind Method; Electroencephalography; Epilepsy; Female; Humans; Lorazepam; Male; Middle Aged; Proof of Concept Study; Pyrrolidinones; Seizures; Sleepiness; Treatment Outcome; Young Adult | 2020 |
2 other study(ies) available for lorazepam and ucb 34714
| Article | Year |
|---|---|
Intravenous brivaracetam and lorazepam for acute seizure control: Are they equally effective?
Topics: Humans; Lorazepam; Pyrrolidinones; Seizures | 2020 |
Response to Letter to the Editor "Intravenous brivaracetam and lorazepam for acute seizure control: Are they equally effective?"
Topics: Administration, Intravenous; Humans; Lorazepam; Pyrrolidinones; Seizures | 2020 |